VYNE News and Press, VYNE Therapeutics Inc Com From 01/13/22

Transaction includes cash payments of $25 million and potential milestones of up to $450 million Sale aligns with VYNE’s strategic plan; proceeds will be used to fund development of Company’s immuno-inflammatory pipeline BRIDGEWATER, N.J., Jan. 13, 2022 (GLOBE NEWSWIRE...

BRIDGEWATER, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that management will participate in one-on-one investor meetings at the LifeSci Partners 11 th Annual Corporate Access Event, ...

Context Therapeutics (NASDAQ:CNTX) +25% on positive ONA-XR data in early breast cancer study. American Virtual Cloud Technologies (NASDAQ:AVCT) +25% Kandy and Braidio announce expanded partnership to accelerate the delivery of digital transformation as a service solutions. Ener...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s the last day of the trading week and we’re starting it with the biggest pre-market stock movers for Friday! Source: Shutterstock Stocks are on the move this morning thanks ...

Why These 4 Penny Stocks on Reddit Are Popular in December Right now, trading penny stocks is extremely popular. And, this has been the case for several years now, as more and more investors discover the potential that penny stocks have to offer. While either penny stocks or blue ...

Gainers: Elevation Oncology (NASDAQ:ELEV) +25%. BeyondSpring (NASDAQ:BYSI) +21%. Nemaura Medical (NASDAQ:NMRD) +18%. Regencell Bioscience Holdings (NASDAQ:RGC) +17%. Novavax (NASDAQ:NVAX) +17%. Losers: HealthEquity (NASDAQ:HQY) -23%. Cumberland Pharmaceuticals (NASDAQ:CPIX) -21%. VY...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips GCP Applied Technologies (NYSE: GCP ) stock is rising higher on Monday thanks to a massive buyout deal from Saint-Gobain . Source: Shutterstock According to a press release , Saint-Gobain will acquire all outs...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips VYNE Therapeutics (NASDAQ: VYNE ) stock price predictions are heating up on Monday with one analyst setting a high goal for the company to reach. Source: luchschenF / Shutterstock.com H.C. Wainwright analyst J...

Shares in VYNE Therapeutics (VYNE +31.8%), a tiny biotech with a market cap of ~$62.6M, are surging today following a buy initiation from H.C. Wainwright. The firm has a $7 price target (669% return). Analyst Joseph Pantginis says that the company has a "reinvigorated" pipeline focused on ski...

Penny Stocks Insiders Decided To Buy This Month Who doesn’t like to take advantage of cheap prices? When it comes to penny stocks, compared to companies like Apple or Amazon, their prices may seem like they offer a steep discount. You also can’t forget that you’re a...